These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7242314)

  • 21. Acute effect of various doses of isosorbide-5-mononitrate on hemodynamic and exercise performance in coronary artery disease.
    Jansen W; Meyer L; Tauchert M
    Am J Cardiol; 1988 Mar; 61(9):31E-35E. PubMed ID: 3348138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The duration of th effect of isosorbide-5-mononitrate--a new anti-anginal agent].
    Kozák P
    Vnitr Lek; 1985 Dec; 31(12):1217-21. PubMed ID: 4090311
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of isosorbide dinitrate on the blood circulation system in patients with ischemic heart disease].
    Gaponenko VA; Santova RA; Chilikina ON; Akhmetova MG; Moskalenko NP; Glezer GA
    Ross Med Zh; 1992; (4):45-7. PubMed ID: 1521022
    [No Abstract]   [Full Text] [Related]  

  • 24. [Long-term tolerance and therapeutic coronary effect of isosorbide-5-mononitrate. Open multicenter study of ISMO 20].
    Uberbacher HJ; Glocke M; Abshagen U
    MMW Munch Med Wochenschr; 1983 Jan; 125(4):76-8. PubMed ID: 6402686
    [No Abstract]   [Full Text] [Related]  

  • 25. [Randomized double-blind comparative study: glycerol trinitrate and isosorbide mononitrate].
    Kayali A
    Med Welt; 1983 Dec; 34(50):1441-4. PubMed ID: 6420639
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hemodynamic effects of isosorbide-5-mononitrate in coronary heart disease. A comparison of acute and chronic treatment].
    Wiechmann HW; Schuster P; Trieb G
    Dtsch Med Wochenschr; 1983 Sep; 108(35):1304-7. PubMed ID: 6884214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of IS-5-MN in coronary disease. Monocentric double-blind crossover comparison with ISDN retard and placebo].
    Müller G; Schmidt-Voigt J
    Med Welt; 1981 Apr; 32(14A):554-6. PubMed ID: 7242319
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative hemodynamic study of IS-5-MN and ISDN in man--which are equieffective doses?
    Vogt A; Bernhardt S; Schwarck H; Stroh E; Kreuzer H
    Z Kardiol; 1983; 72 Suppl 3():182-4. PubMed ID: 6666220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute effect of isosorbide mononitrate on blood circulation and myocardial ischemia in patients with atherosclerosis].
    Solimene MC
    Arq Bras Cardiol; 1995 Jul; 65(1):79-80. PubMed ID: 8546602
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of isosorbide nitrate, isosorbide-2- and 5-mononitrate on the exertion ECG and on the hemodynamics during atrial stimulation in patients with angina pectoris].
    Stauch M; Grewe N
    Z Kardiol; 1979 Oct; 68(10):687-93. PubMed ID: 516844
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of isosorbide-5-mononitrate, metipranolol and a combination of the two in experimental myocardial ischemia in the awake dog].
    Sponer G; Voss E; Dietmann K
    Med Welt; 1981 Apr; 32(14A):492-6. PubMed ID: 6113532
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ergometric and clinical results of treating coronary disease with isosorbide dinitrate and verapamil].
    Pozenel H
    Med Welt; 1981 Jun; 32(24):988-92. PubMed ID: 7253907
    [No Abstract]   [Full Text] [Related]  

  • 33. Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate.
    Jost S
    Eur Heart J; 1992 May; 13(5):720. PubMed ID: 1618218
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of 50 mg isosorbide-5-nitrate retard on the stress tolerance of patients with coronary heart disease].
    Eggeling T; Jansen W; Osterspey A; Tauchert M; Hilger HH
    Med Klin (Munich); 1986 Apr; 81(8):275-80. PubMed ID: 3785087
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of sublingual isosorbide dinitrate on hemodynamics in coronary patients with and without congestive heart failure (author's transl)].
    Wolf R; Beck OA; Habel F; Hochrein H
    Z Kardiol; 1977 Aug; 66(8):459-64. PubMed ID: 899150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative antianginal, hemodynamic and pharmacokinetic effects of isosorbide-2-mononitrate and isosorbide dinitrate in the rat].
    Leitold M; Laufen H
    Arzneimittelforschung; 1983; 33(8):1117-21. PubMed ID: 6685489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic effects of oral and sublingual forms of isosorbide dinitrate in patients with acute coronary insufficiency.
    Poliner LR; Ritter W; Wohl AJ; Nixon JV; Willerson JT
    Tex Med; 1977 Feb; 73(2):53-8. PubMed ID: 841487
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of isosorbide-5-mononitrate in the prevention of myocardial ischemia induced by ergonovine and by hand-grip tests.
    Distante A; Lombardi M; Moscarelli E; Morales MA; Sabino F; L'Abbate A
    Z Kardiol; 1985; 74 Suppl 4():25-31. PubMed ID: 4096068
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effectiveness and duration of effect of molsidomine and isosorbide dinitrate in peripheral circulation].
    König FK; Grewe R; Wörz K
    Fortschr Med; 1985 Oct; 103(38):903-6. PubMed ID: 3908257
    [No Abstract]   [Full Text] [Related]  

  • 40. [Long-term therapy with nitrates. Relation between dosage and tolerance effect].
    Tauchert M; Jansen W; Metternich M; Osterspey A
    Herz; 1984 Jun; 9(3):153-65. PubMed ID: 6430769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.